Phase I study of MOV18, a first in class chimeric IgE antibody against folate receptor-α, in patients with advanced solid tumours: pre-clinical and clinical evaluations.

Project: Research

Project Details

StatusFinished
Effective start/end date1/05/2015 → 31/07/2022

Funding

  • CRUK Cancer Research UK: £37,955.00
  • CRUK Cancer Research UK: £166,045.00
  • CRUK Cancer Research UK: £26,437.00
  • CRUK Cancer Research UK: £8,262.88
  • CRUK Cancer Research UK: £29,887.90
  • CRUK Cancer Research UK: £32,495.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint